secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001193125-24-159193
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech stockholders elect three directors and ratify EY as auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Kathleen Sereda Glaub, Peter Hirth, and Mai-Britt Zocca elected as Class III directors until 2027.
- Votes for each director exceeded 42 million; broker non-votes 3.9 million on each.
- Ratification of EY as independent auditor for FY 2024 approved with 47.2 million for, 67k against.
- No other matters were voted on at the June 6, 2024 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524159193/0001193125-24-159193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524159193/d768244d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-159193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer